ESC 365 - Titanium-nitride-oxide-coated vs drug-eluting stents in acute coronary syndromes during five-year follow-up: an individual patient data meta-analysis

ESC Professional Premium Access

Titanium-nitride-oxide-coated vs drug-eluting stents in acute coronary syndromes during five-year follow-up: an individual patient data meta-analysis

Session: Trial updates and other studies on percutaneous coronary intervention

Topic: Revascularisation

Speaker: Doctor T. Mahendiran (Aalst, BE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Thabo Mahendiran

Cardiovascular Research Center Aalst, Aalst (Belgium)

1 presentation

0 follower

4 more presentations in this session

Clopidogrel following 1-month aspirin-free low-dose prasugrel monotherapy versus aspirin following 1-month DAPT after PCI for patients with ACS or HBR: Final 1-year results from the STOPDAPT-3

Speaker: Doctor H. Watanabe (Hirakata, JP)

Long-Term Outcomes with PCI Guided by Fractional Flow Reserve

Speaker: Doctor C. Collet (Aalst, BE)

Physiology-guided complete versus culprit-only PCI in older MI patients

Speaker: Doctor S. Biscaglia (Ferrara, IT)

A comparison of prolonged anticoagulation versus no anticoagulation after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction

Speaker: Associate Professor Y. Yan (Beijing, CN)

Access the full session

Trial updates and other studies on percutaneous coronary intervention

Speakers: Doctor T. Mahendiran, Doctor H. Watanabe, Doctor C. Collet, Doctor S. Biscaglia, Associate Professor Y. Yan

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources